Collaborative Drug Discovery (CDD)

Supercharging the silo

Sophia Ktori explores the role bioinformatics software plays in helping scientists to make sense of complex scientific data

How can biotech companies optimize data access while going virtual?

This article is brought to you by: 

There is mounting pressure for companies to ensure that non-essential personnel work from home. The challenge, of course, is to operate in a virtual capacity without sacrificing productivity – in particular for biotech companies engaging in drug discovery where timely access to data can make or break an organization.

Synergy between man and machine

The failure of a candidate drug can cost millions – so many chemists are turning to software that provides modelling capabilities and multi-parameter optimisation

Subscribe to RSS - Collaborative Drug Discovery (CDD)